Webinars:
On Demand
Drug development for start-ups and emerging pharma (Part 1 of 2)
- Anders Högdin, Ph.D, Senior Business Development Director, Drug Substance, Recipharm AB
- Mikael Bisrat, PhD, Senior Business Development Director, Drug Product, Recipharm AB
- Gabriella Yousef, Formulation Scientist
- Aaron Small, Vice President, Global Development Sales, Recipharm AB
- Mikael Bisrat, PhD, Senior Business Development Director, Drug Product, Recipharm AB
- Gabriella Yousef, Formulation Scientist
- Aaron Small, Vice President, Global Development Sales, Recipharm AB
From drug candidate to proof of concept (POC)
The drug development for start-ups and emerging pharma webinar is the first of a two-part series covering development from drug candidate to launch. This first webinar will focus on the steps from drug candidate to proof of concept (POC).
Key learning objectives:
- Get a clear view of the important steps of drug development until proof of concept;
- How to reduce risks in the development process;
- Understand the timeline and critical steps;
- Importance of having the end product in mind from the start;
Drug development for start-ups and emerging pharma (Part 2 of 2)
- Torkel Gren, PhD, Senior Director, Technology Officer & Strategic Investments Recipharm AB
- Aaron Small, Vice President Global Development Sales Recipharm AB
- Stefan Kosharevski, Host, Business Review Webinars
- Aaron Small, Vice President Global Development Sales Recipharm AB
- Stefan Kosharevski, Host, Business Review Webinars
From drug proof of concept (POC) to launch
The drug development for start-ups and emerging pharma webinar is the first of a two-part series covering development from drug candidate to launch.
Key learning objectives:
- Get a clear view of the important steps of drug development from proof of concept until launch;
- How to reduce risks in the development process;
- Understand the time line and critical steps;
- Importance of having the end product in mind from the start;
